2005;293:2126 30. 31. Melloni C, Peterson ED, Chen AY, et al. Cockcroft-Gault versus modi- fication of diet in renal disease: importance of glomerular filtration rate formula for classification of chronic kidney disease in patients with non- ST-segment elevation acute coronary syndromes. J Am Coll Cardiol 2008;51:991 6. Nallamothu et al ACC/AHA/SCAI/AMA-PCPI/NCQA 2013 PCI Performance Measure 941 32. Gurm HS, Dixon SR, Smith DE, et al. Renal function-based contrast dosing to define safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 2011;58:907 14. 33. Schweiger MJ, Chambers CE, Davidson CJ, et al. Prevention of con- trast induced nephropathy: recommendations for the high risk patient undergoing cardiovascular procedures. Catheter Cardiovasc Interv 2007;69:135 40. 34. Stacul F, van der MolenAJ, Reimer P, et al. Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol. 2011;21:2527 41. 35. Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for pre- diction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 2004;44:1393 9. 36. Borden WB, Redberg RF, Mushlin AI, et al. Patterns and intensity of med- ical therapy in patients undergoing percutaneous coronary intervention. JAMA. 2011;305:1882 9. heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP). Am J Cardiol. 2001;87:819 22. 38. National Cardiovascular Data Registry. Measures and Metrics.Available at: https://www.ncdr.com/WebNCDR/home/metrics-and-measures. Accessed May 10, 2013. 39. Goel K, Lennon RJ, Tilbury RT, et al. Impact of cardiac rehabilitation on mortality and cardiovascular events after percutaneous coronary interven- tion in the community. Circulation 2011;123:2344 52. 40. Taylor RS, Brown A, Ebrahim S, et al. Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am J Med. 2004;116:682 92. 41. Giannuzzi P, Temporelli PL, Marchioli R, et al. 